Comparison of Neoral and Sandimmun Cyclosporines for De Novo Lung Transplantation in Cystic Fibrosis Patients

By Mikhail G.   Eadon H.   Leaver N.   Khaghani A.   Yacoub M.   Banner N.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1510-1511

Elsevier

Access to resources Recommend Favorite

The pharmacokinetics of oral cyclosporin a (neoral) during the first month after bone marrow transplantation

By Schultz K.R.   Nevill T.J.   Toze C.L.   Corr T.   Currie C.   Strong D.K.   Keown P.A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1668-1670

Elsevier

Access to resources Recommend Favorite

Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity

By Shaheen F.A.M.   Sheikh I.A.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3294-3294

Elsevier

Access to resources Recommend Favorite

Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus

By Boyacioglu S.   Gur G.   Yilmaz U.   Korkmaz M.   Demirhan B.   Bilezikci B.   Ozdemir N.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 50-52

Elsevier

Access to resources Recommend Favorite

Cyclosporin neoral and long-term survival of renal grafts

By Shaheen F.A.M.   Sheikh I.A.   Al-Khader A.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3549-3549

Elsevier

Access to resources Recommend Favorite